Replay available

Progyny, Inc. (PGNY) Q2 2026 Earnings Call

Progyny, Inc. (NASDAQ: PGNY) Q2 2026 earnings conference call, held 2026-08-06. Replay captured from the company's public earnings webcast.

Thu, August 6, 2026 at 4:45 PMendedReplay
Progyny, Inc. (PGNY) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

James Hart

Head of Investor Relations

Peter Anevski

CEO

Mark Livingston

CFO

Replay transcript excerpt

Ladies and gentlemen, and welcome to the Progeny, Inc. second quarter 2026 earnings conference call. At this time, all participants are on a listen-only mode, and the floor will be open for questions and comments after the presentation. If you wish to join the queue at any time to ask a question, you can press star 1 on your telephone keypad. Should you wish to remove yourself from queue, you can press star 2. It is now my pleasure to turn the call over to your host, James Hart. James, the floor is yours. Thank you, Tom, and good afternoon, everyone. Welcome to our second quarter conference call. With me today are Peter Anevski, CEO of Progeny, and Mark Livingston, CFO. We will begin with some prepared remarks before we open the call for your questions. Before we begin, I'd like to remind you that our comments and responses to your questions today reflect management's views as of today only and will include statements related to our financial outlook for both the third quarter and full year 2026 and the assumptions and drivers underlying such guidance, the demand for our solutions, our expectations for our selling season for 2027 launches, anticipated employment levels of our clients and the industries that we serve, the timing of client decisions, our expected utilization rates and mix, The potential benefits of our solution are our ability to acquire new clients and retain and upsell existing clients, our market opportunity, and our business strategy, plans, goals, and expectations concerning our market position, future operations, and other financial and operating information, which are forward-looking statements under the federal securities law. Actual results may differ materially from those contained in or implied by these forward-looking statements, Thank you ...

More from Progyny, Inc.